|
Cautions |
Hepatic impairment |
Renal impairment |
Loading dose |
Maintenance dose |
Clopidogrel(Plavix) |
* Contraindications |
Use caution |
Not necessary |
600mg |
150 for 7days, |
Prasugrel(Effient) |
* Contraindications |
In severe: not studied |
Not necessary |
60mg |
10mg |
Ticagrelor(Brilinta) |
* Contraindications |
Contraindicated in severe state Caution in moderate state |
NO dose adjustment |
180mg |
90mg q12hr |
*Maximal platelet aggregation, Acute Coronary
Syndrome 후 mortality 로 봤을 때
Ticagrelor > Pragsugrel >
Clopidogrel
*In patients ≥ 75 years of age, Effient is generally not recommended, because of the increased risk of fatal and intracranial bleeding and uncertain benefit, except in high-risk situations (patients with diabetes or a history of prior MI) where its effect appears to be greater and its use may be considered
REFERENE
1. Clopidogrel, Prasugrel, Tacegerlor, ACC, 2013
2. Medscape
3. Prescribing informations
brilinta prescribing information.pdf
Effient prescribing informations.pdf